1. Home
  2. GNPX vs MSN Comparison

GNPX vs MSN Comparison

Compare GNPX & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • MSN
  • Stock Information
  • Founded
  • GNPX 2009
  • MSN 1948
  • Country
  • GNPX United States
  • MSN United States
  • Employees
  • GNPX N/A
  • MSN N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • MSN Consumer Electronics/Appliances
  • Sector
  • GNPX Health Care
  • MSN Consumer Staples
  • Exchange
  • GNPX Nasdaq
  • MSN Nasdaq
  • Market Cap
  • GNPX 6.6M
  • MSN 8.6M
  • IPO Year
  • GNPX 2018
  • MSN 1994
  • Fundamental
  • Price
  • GNPX $0.23
  • MSN $0.39
  • Analyst Decision
  • GNPX
  • MSN
  • Analyst Count
  • GNPX 0
  • MSN 0
  • Target Price
  • GNPX N/A
  • MSN N/A
  • AVG Volume (30 Days)
  • GNPX 3.6M
  • MSN 15.5K
  • Earning Date
  • GNPX 08-08-2025
  • MSN 06-27-2025
  • Dividend Yield
  • GNPX N/A
  • MSN N/A
  • EPS Growth
  • GNPX N/A
  • MSN N/A
  • EPS
  • GNPX N/A
  • MSN N/A
  • Revenue
  • GNPX N/A
  • MSN $11,140,000.00
  • Revenue This Year
  • GNPX N/A
  • MSN N/A
  • Revenue Next Year
  • GNPX N/A
  • MSN N/A
  • P/E Ratio
  • GNPX N/A
  • MSN N/A
  • Revenue Growth
  • GNPX N/A
  • MSN 27.46
  • 52 Week Low
  • GNPX $0.20
  • MSN $0.35
  • 52 Week High
  • GNPX $3.97
  • MSN $0.83
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 40.22
  • MSN 42.00
  • Support Level
  • GNPX $0.22
  • MSN $0.41
  • Resistance Level
  • GNPX $0.32
  • MSN $0.42
  • Average True Range (ATR)
  • GNPX 0.03
  • MSN 0.03
  • MACD
  • GNPX -0.01
  • MSN -0.00
  • Stochastic Oscillator
  • GNPX 22.07
  • MSN 7.86

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About MSN Emerson Radio Corporation

Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. Its products are offered to encompass televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products. geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: